SCOPUS 정보 검색 플랫폼

Cancer Biotherapy and Radiopharmaceuticals

Volumn 16, Issue 5, 2001, Pages 371-379

Biokinetics of a F(ab′)3iodine-131 labeled antigen binding construct (MAb 35) directed against CEA in patients with colorectal carcinoma

(8) Storto, G a Buchegger, F a Waibel, R b Kuenzi, G c Offord, R E c Schubiger, P A b Gillet, M a Delaloye, A Bischof a

a Department of Nuclear Medicine ^* (Switzerland)

b PAUL SCHERRER INSTITUTE (Switzerland)

c UNIVERSITY OF GENEVA (Switzerland)

Author keywords

Anti CEA; Colorectal cancer; Liver metastases; Radioimmunotherapy

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IODINE 131;

ADULT; AGED; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLORECTAL CARCINOMA; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG TISSUE LEVEL; FEMALE; HALF LIFE TIME; HUMAN; ISOTOPE LABELING; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SCINTISCANNING;

ADENOCARCINOMA; AGED; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HALF-LIFE; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN FAB FRAGMENTS; IODINE RADIOISOTOPES; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; MICE; MIDDLE AGED; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION;

EID: 0035216149 PISSN: 10849785 EISSN: None Source Type: Journal
DOI: 10.1089/108497801753354276 Document Type: Article

Times cited : (9)

References (28)

1
- 0028204147
- Colorectal carcinoma - Current problems and future perspectives
- (1994) Ann Oncol , vol.5 , pp. 115-121
- Schmoll, H.J.¹

2
- 0030992552
- Comparison of 67Cu- and 1251-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors
- (1997) J Nucl Med , vol.38 , pp. 847-853
- Bischof Delaloye, A.¹ Delaloye, B.² Buchegger, F.³ Vogel, G.A.⁴ Gillet, M.⁵ Mach, J.-P.⁶ Smith, A.⁷ Schubigher, P.A.⁸

3
- 0032697131
- Strategies for developing effective radio-immunotherapy for solid tumors
- (1999) Clin Cancer Res , vol.5 , pp. 3219s-3223s
- DeNardo, G.L.¹ O’Donnell, R.T.² Kroger, L.A.³ Richman, C.M.⁴ Goldstein, L.⁵ DeNardo, S.J.⁶

4
- 0007003417
- Radioimmunotherapy of small volume disease of colorectal cancer: Results of an ongoing phase-II trial with the I-131-labeled humanized anti-CEA antibody, hMN-14
- (2000) Eur J Nucl Med , vol.27 , pp. 951
- Behr, T.M.¹ Liersch, T.² Griesinger, F.³ Behe, M.⁴ Gratz, S.⁵ Becker, H.⁶ Goldenberg, D.M.⁷ Becker, W.⁸

5
- 0029015471
- Radio-labelled monoclonal antibodies in tumor imaging and therapy: Out of fashion?
- (1995) Eur J Nucl Med , vol.22 , pp. 571-580
- Bischof Delaloye, A.¹ Delaloye, B.²

6
- 0024460887
- Clinical value of immunoscintigraphy in colorectal carcinoma patients: A prospective study
- (1989) J Nucl Med , vol.30 , pp. 1646-1656
- Bischof Delaloye, A.¹ Delaloye, B.² Buchegger, F.³ Gilgien, W.⁴ Studer, A.⁵ Curchod, S.⁶ Givel, J.-C.⁷ Mosiman, F.⁸ Pettavel, J.⁹ Mach, J.-P.¹⁰

7
- 0028907602
- Comparison of complete versus fragmented Tc99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer
- (1995) J Nucl Med , vol.36 , pp. 430-441
- Behr, T.M.¹ Becker, W.S.² Bair, H.-J.³ Klein, M.W.⁴ Stuhler, C.M.⁵ Cidlinsky, K.P.⁶ Wittekind, C.W.⁷ Scheele, J.R.⁸ Wolf, F.G.⁹

8
- 0022570716
- 2fragments from monoclonal anti-carcinoembryonic antigen antibodies
- (1986) J Clin Invest , vol.177 , pp. 301-311
- Delaloye, B.¹ Bischof Delaloye, A.² Buchegger, F.³ Von Fliedner, V.⁴ Grob, J.P.⁵ Volant, J.C.⁶ Pettavel, J.⁷ Mach, J.-P.⁸

9
- 0028926012
- Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody in surgically treated colorectal carcinoma
- (1995) J Nucl Med , vol.36 , pp. 420-429
- Buchegger, F.¹ Mach, J.-P.² Pèlegrin, A.³ Gillet, M.⁴ Vogel, C.⁵ Buclin, T.⁶ Ryser, J.E.⁷ Delaloye, B.⁸ Bischof Delaloye, A.⁹

10
- 0033054395
- Three-step radioimmunotherapy with Y-90 biotin: Dosimetry and pharmacokinetics in cancer patients
- (1999) Eur J Nucl Med , vol.26 , pp. 110-120
- Cremonesi, M.¹ Ferrari, M.² Chinol, M.³ Stabin, M.G.⁴ Grana, C.⁵ Prisco, G.⁶ Robertson, C.⁷ Tosi, G.⁸ Paganelli, G.⁹

11
- 18544410002
- Pretargeted radio-immunotherapy (PRIT) for treatment of non-Hodgkin’s lymphoma (NHL): Initial phase I/II study results
- (2000) Cancer Biother Radiopharm , vol.15 , Issue.1 , pp. 15-29
- Weiden, P.L.¹ Breitz, H.B.² Press, O.³ Appelbaum, J.W.⁴ Bryan, J.K.⁵ Gaffigan, S.⁶ Stone, D.⁷ Axworthy, D.⁸ Fisher, D.⁹ Reno, J.¹⁰

12
- 0025330441
- 2fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice
- (1990) J Nucl Med , vol.31 , Issue.6 , pp. 1035-1044
- Buchegger, F.¹ Pèlegrin, A.² Delaloye, B.³ Bischof Delaloye, A.⁴ Mach, J.-P.⁵

13
- 0028892309
- Targeting of liver metastases of colorectal cancer with IgG and Fab′ anti-CEA antigen antibodies labeled 99mTc: The role of metabolism and kinetics
- (1995) Cancer Res , vol.55 , pp. 5777s-5785s
- Behr, T.¹ Becker, W.² Hannappel, E.³ Goldenberg, D.M.⁴ Wolf, F.⁵

14
- 0032727515
- Dosimetric evaluation and radioimmunotherapy of anti-tumor multivalent Fab′ fragments
- (1999) Br J Cancer , vol.81 , Issue.6 , pp. 972-980
- Casey, J.L.¹ Pedley, R.B.² King, D.J.³ Green, A.J.⁴ Yarranton, G.T.⁵ Begent, R.⁶

15
- 0029890636
- Minibody: A novel engineered anti-CEA antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid level targeting of xenografts
- (1996) Cancer Res , vol.56 , Issue.13 , pp. 3055-3061
- Hu, S.¹ Shively, L.² Raubitschek, A.³ Sherman, M.⁴ Williams, L.E.⁵ Wong, J.⁶ Wu, A.M.⁷

16
- 0030020157
- Preparation of a trivalent antigenbinding construct, using polyoxime chemistry: Improved biodistribution and potential for therapeutic application
- (1996) Cancer Res , vol.56 , pp. 809-815
- Werlen, R.C.¹ Lankinen, M.² Offord, R.E.³ Schubiger, P.A.⁴ Smith, A.⁵ Rose, K.⁶

17
- 0020571717
- Monoclonal antibodies to carcinoembryonic antigen: Ionic strength as a factor in the selection of antibodies for immunoscintigraphy
- (1983) Cancer Res , vol.43 , pp. 3857-3864
- Haskell, C.N.¹ Buchegger, F.² Schreyer, M.³ Carrel, S.⁴ Mach, J.-P.⁵

18
- 0028535272
- High-yield, site-specific coupling of N-terminally modified β-lactamase proteolytically derived single-sulfhydryl murine Fab′
- (1994) Bioconjugate Chem , vol.5 , pp. 636-646
- Mikolajczyk, S.D.¹ Meyer, D.L.² Starling, J.J.³ Law, K.L.⁴ Rose, K.⁵ Dufour, B.⁶ Offord, R.E.⁷

19
- 0021236693
- Determination of the immunoreactive fraction of monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
- (1984) J Immunol Methods , vol.72 , pp. 77-89
- Lindmo, T.¹ Boven, E.² Cutitta, F.³ Fedorko, J.⁴ Bunn, P.A.⁵

20
- 0034662510
- Radioimmunotherapy with I-131 tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: Updated results and longterm follow-up of the University of Michigan experience
- (2000) Blood , vol.96 , pp. 1259-1266
- Kaminski, M.S.¹ Estes, J.² Zasadny, K.R.³ Francis, I.R.⁴ Ross, C.W.⁵ Tuck, M.⁶ Regan, D.⁷ Fisher, S.⁸ Gutierrez, J.⁹ Kroll, S.¹⁰ Stagg, R.¹¹ Tidmarsh, G.¹² Wahl, R.L.¹³

21
- 0034005508
- Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: The Seattle experience
- (2000) Annals of Hematology , vol.79 , pp. 175-182
- Johnson, T.A.¹ Press, O.W.²

22
- 0033976335
- Neovascular targeting with cyclic RGD peptide (cRGDf-AC) to enhance delivery of radioimmunotherapy
- (2000) Cancer Biother Radiopharm , vol.15 , pp. 71-79
- DeNardo, S.J.¹ Burke, P.A.² Leigh, B.R.³ O’Donnell, R.T.⁴ Miers, L.A.⁵ Kroge, S.⁶ Goodman, S.L.⁷ Matzku, S.⁸ Jonczyk, A.⁹ Lamborn, K.R.¹⁰ DeNardo, G.L.¹¹

23
- 0029278795
- Tumor imaging with monoclonal antibodies
- (1995) Seminars in Nuclear Medicine , vol.25 , pp. 144-164
- Bischof Delaloye, A.¹ Delaloye, B.²

24
- 0027508143
- 2fragment in nude mice bearing different human colon cancer xenografts
- (1993) Br J of Cancer , vol.68 , pp. 684-690
- Vogel, C.¹ Bischof Delaloye, A.² Mach, J.-P.³ Pèlegrin, A.⁴ Hardman, N.⁵ Delaloye, B.⁶ Buchegger, F.⁷

25
- 0033833117
- ScFv multimers of the anti-neuraminidase antibody NC10: Shortening of the linker in single-chain Fv fragment assembly V(L) to V (H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers
- (2000) Protein Eng , vol.13 , pp. 565-574
- Dolezal, O.¹ Pearce, L.A.² Lawrence, L.J.³ McCoy, A.J.⁴ Hudson, P.J.⁵ Kortt, M.⁶

26
- 0034671309
- Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application
- (2000) Cancer Research , vol.60 , pp. 6964-6971
- Goel, A.¹ Colcher, D.² Baranowska-Kortylewicz, J.³ Augustine, S.⁴ Booth, B.J.M.⁵ Pavlinkova, G.⁶ Batra, S.K.⁷

27
- 0034541209
- A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy
- (2000) Cancer Res , vol.60 , pp. 6663-6669
- Schultz, J.¹ Lin, Y.² Sanderson, J.³ Zuo, Y.⁴ Stone, D.⁵ Mallett, R.⁶ Wilbert, S.⁷ Axworthy, D.⁸

28
- 0022915868
- Tumor size: Effect of monoclonal antibody uptake in tumor models
- (1986) J Nucl Med , vol.27 , pp. 422-427
- Hagan, P.L.¹ Halpern, S.E.² Dillman, R.O.³ Shawler, D.L.⁴ Johnson, D.E.⁵ Chen, A.⁶ Krishnan, L.⁷ Frincke, J.⁸ Bartholomew, R.M.⁹ David, G.S.¹⁰ Carlo, D.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.